About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 295153, 8 pages
http://dx.doi.org/10.1155/2013/295153
Review Article

Albumin Reduces Paracentesis-Induced Circulatory Dysfunction and Reduces Death and Renal Impairment among Patients with Cirrhosis and Infection: A Systematic Review and Meta-Analysis

1Norfolk and Norwich University Hospital, Colney Lane, Norwich NR4 7UY, UK
2Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK

Received 30 April 2013; Revised 31 July 2013; Accepted 5 August 2013

Academic Editor: Ahmed Abdel-Latif

Copyright © 2013 Chun Shing Kwok et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Ruiz-Del-Arbol, A. Monescillo, W. Jimenez, A. Garcia-Plaza, V. Arroyo, and J. Rodes, “Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis,” Gastroenterology, vol. 113, no. 2, pp. 579–586, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Gines, L. Tito, V. Arroyo et al., “Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis,” Gastroenterology, vol. 94, no. 6, pp. 1493–1502, 1988. View at Scopus
  3. P. Ginès and A. Cárdenas, “The management of ascites and hyponatremia in cirrhosis,” Seminars in Liver Disease, vol. 28, no. 1, pp. 43–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Salerno, M. Guevara, M. Bernardi et al., “Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis,” Liver International, vol. 30, no. 7, pp. 937–947, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. B. A. Runyon, “Management of adult patients with ascites due to cirrhosis: update 2012,” AASLD Practice Guidelineshttp://www.aasld.org/practiceguidelines/Documents/ascitesupdate2013.pdf.
  6. P. Ginès, P. Angeli, K. Lenz et al., “EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis,” Journal of Hepatology, vol. 53, no. 3, pp. 397–417, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Fernández, M. Navasa, J. C. Garcia-Pagan et al., “Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis,” Journal of Hepatology, vol. 41, no. 3, pp. 384–390, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Sort, M. Navasa, V. Arroyo et al., “Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis,” The New England Journal of Medicine, vol. 341, no. 6, pp. 403–409, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Fernández, M. Navasa, J. Gómez et al., “Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis,” Hepatology, vol. 35, no. 1, pp. 140–148, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Wong, M. Bernardi, R. Balk et al., “Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club,” Gut, vol. 54, no. 5, pp. 718–725, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Tandon and G. Garcia-Tsao, “Bacterial infections, sepsis, and multiorgan failure in cirrhosis,” Seminars in Liver Disease, vol. 28, no. 1, pp. 26–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Arvaniti, G. D'Amico, G. Fede et al., “Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis,” Gastroenterology, vol. 139, no. 4, pp. 1246–1256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Follo, J. M. Llovet, M. Navasa et al., “Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis,” Hepatology, vol. 20, no. 6, pp. 1495–1501, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Gustot, F. Durand, D. Lebrec, J.-L. Vincent, and R. Moreau, “Severe sepsis in cirrhosis,” Hepatology, vol. 50, no. 6, pp. 2022–2033, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. B. A. Runyon, “Albumin infusion for spontaneous bacterial peritonitis,” The Lancet, vol. 354, no. 9193, pp. 1838–1839, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Tandon and G. Garcia-Tsao, “Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis,” Clinical Gastroenterology and Hepatology, vol. 9, no. 3, pp. 260–265, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Guevara, V. Arroyo, and P. Gines, “Effect of albumin on survival in septic cirrhotic patients other than spontaneous bacterial peritonitis. The question remains open,” Journal of Hepatology, vol. 58, no. 3, pp. 640–649, 2013.
  18. http://hiru.mcmaster.ca/hiru/HIRU_Hedges_EMBASE_Strategies.aspx, and, http://hiru.mcmaster.ca/hiru/HIRU_Hedges_MEDLINE_Strategies.aspx.
  19. E. E. Abdel-Khalek and S. E. Arif, “Randomized trial comparing human albumin and hydroxyethyl starch 6% as plasma expanders for treatment of patients with liver cirrhosis and tense ascites following large volume paracentesis,” Arab Journal of Gastroenterology, vol. 11, no. 1, pp. 24–29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Altman, B. Bernard, D. Roulot, R.-L. Vitte, and O. Ink, “Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis,” European Journal of Gastroenterology and Hepatology, vol. 10, no. 1, pp. 5–10, 1998. View at Scopus
  21. C. H. Choi, K. H. Han, D. Y. Kim et al., “Efficacy and safety of large volume paracentesis in cirrhotic patients with spontaneous bacterial peritonitis: a randomized prospective study,” The Korean Journal of Hepatology, vol. 8, no. 1, pp. 52–60, 2002. View at Scopus
  22. E. Fassio, R. Terg, G. Landeira et al., “Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study,” Journal of Hepatology, vol. 14, no. 2-3, pp. 310–316, 1992. View at Scopus
  23. D. Garcia-Compean, J. Z. Villarreal, H. B. Cuevas et al., “Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial,” Liver, vol. 13, no. 5, pp. 233–238, 1993. View at Scopus
  24. D. García-Compean, P. Blanc, D. Larrey et al., “Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial,” Annals of Hepatology, vol. 1, no. 1, pp. 29–35, 2002. View at Scopus
  25. A. Gines, G. Fernandez-Esparrach, A. Monescillo et al., “Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis,” Gastroenterology, vol. 111, no. 4, pp. 1002–1010, 1996. View at Scopus
  26. M. Guevara, C. Terra, A. Nazar, E. Sola, J. Fernandez, M. Pavesi, et al., “Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study,” Journal of Hepatology, vol. 57, no. 4, pp. 759–765, 2012. View at Publisher · View at Google Scholar
  27. R. Moreau, D.-C. Valla, I. Durand-Zaleski et al., “Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trial,” Liver International, vol. 26, no. 1, pp. 46–54, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Nazar, M. Guevara, C. Terra, M. Martin-Llahi, M. E. Baccaro, M. Pavesi, et al., “Effect of albumin administration in patients with cirrhosis and bacterial infection other than spontaneous bacterial peritonitis. A randomized controlled study,” Journal of Hepatology, vol. 50, p. S86, 2009.
  29. R. Planas, P. Gines, V. Arroyo et al., “Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis: Results of a randomized study,” Gastroenterology, vol. 99, no. 6, pp. 1736–1744, 1990. View at Scopus
  30. J. Sola-Vera, J. Miñana, E. Ricart et al., “Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites,” Hepatology, vol. 37, no. 5, pp. 1147–1153, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. H. P. Xue, B. Lin, J. Z. Mo, and J. Q. Li, “Effect of albumin infusion on preventing the deterioration of renal function in patients with spontaneous bacterial peritonitis,” Chinese Journal of Digestive Diseases, vol. 3, no. 1, pp. 32–34, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. J. P. T. Higgins and S. Green, Cochrane Handbook For Systematic Reviews of Interventions Version 5.0.2, The Cochrane Collaboration, 2009, www.cochrane-handbook.org.
  33. J. P. T. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, “Measuring inconsistency in meta-analyses,” British Medical Journal, vol. 327, no. 7414, pp. 557–560, 2003. View at Scopus
  34. R. Moreau, D.-C. Valla, I. Durand-Zaleski et al., “Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trial,” Liver International, vol. 26, no. 1, pp. 46–54, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Salerno, S. Badalamenti, E. Lorenzano, P. Moser, and P. Incerti, “Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites,” Hepatology, vol. 13, no. 4, pp. 707–713, 1991. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Bernardi, P. Caraceni, R. J. Navickis, and M. M. Wilkes, “Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials,” Hepatology, vol. 55, no. 4, pp. 1172–1181, 2012. View at Publisher · View at Google Scholar · View at Scopus